Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Anti-infective Strategy Following Pancreaticoduodenectomy in Patients With Preoperative Biliary Stent
NCT06123169Phase 3Not yet recruiting
- Sponsor
- Rouen University Hospital
- Start
- Jul 2026
- Primary completion
- Sep 2028
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised trial of piperacillin and tazobactam in surgical site infection (SSI) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Presence of an organ/space Surgical Site Infection at 90 days. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
piperacillintazobactam
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06123169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123169.